Geoffrey L. Smith
From Wikipedia, the free encyclopedia
Professor Geoffrey Lilley Smith FRS FMedSci FIBiol[1], is a British scientist and medical research authority in the area of Vaccinia virus and the family of Poxviruses.
Dr. Smith is editor-in-chief of the Journal of General Virology and chairs the WHO's Advisory Committee on Variola Virus Research[2]. Between 1981–1984, whilst working in the United States under the National Institutes of Health, he developed and pioneered the use of genetically engineered live vaccines.[3]
In 2002 Dr. Smith was elected as a Fellow of the Academy of Medical Sciences. In 2003 he was invited to become a Fellow of the Royal Society[4][5] and in 2005 was awarded the Feldburg Foundation Prize for his work on poxviruses[6].
As of 2008 he remains the Head of the Department of Virology at Imperial College London.[1] Prior to 2002, he was based at the Sir William Dunn School of Pathology at the University of Oxford.[7] Between 1988–1992 his work was funded by The Lister Institute[8].
His maternal grandfather was Ralph Lilley Turner.
[edit] References
- ^ a b Imperial College London, Contact details: Professor Geoffrey L Smith, retrieved 2008-05-09.
- ^ World Health Organisation, WHO Advisory Committee on Variola Virus Research. Report of the Ninth Meeting, covering 2007-11-30.
- ^ ESRC Genomics Policy and Research Forum, Press-release, Are cures for diseases dangerous weapons? Notes to Editors. Speakers' biographies, 2007-04-02.
- ^ Guardian Unlimited, Royal Society names nine women fellows, 2003-05-19.
- ^ Royal Society, Press-release, Record number of women join Royal Society Fellowship, 2003-05-19.
- ^ Imperial College London, press-release, Geoffrey Smith wins Feldburg Foundation Prize, 2005-01-13.
- ^ World Intellectual Property Organization, (WO/1998/037217) A Soluble Vaccinia Virus Protein that Binds Chemokines, published 1998-08-27.
- ^ The Lister Institute for Preventive Medicine, FORMER FELLOWS OF THE LISTER INSTITUTE, retrieved 2008-05-09.